CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock and Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024		47,823
Beginning balance at Dec. 31, 2024	$ 2,951,125	$ 706,817	$ 2,292,819	$ (48,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	270,061		270,061
Other comprehensive income	24,820			24,820
Dividends and dividend equivalents declared	(151,801)		(151,801)
Common stock issued (in shares)		73
Common stock issued	$ 5,335	$ 5,335
Repurchases of common stock (in shares)	(4,000)	(4)
Repurchases of common stock	$ (2,484)	$ (2,484)
Stock-based compensation expense	112,914	$ 112,914
Ending balance (in shares) at Jun. 30, 2025		47,892
Ending balance at Jun. 30, 2025	3,209,970	$ 822,582	2,411,079	(23,691)
Beginning balance (in shares) at Mar. 31, 2025		47,877
Beginning balance at Mar. 31, 2025	3,073,629	$ 764,959	2,351,994	(43,324)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	135,009		135,009
Other comprehensive income	19,633			19,633
Dividends and dividend equivalents declared	(75,924)		(75,924)
Common stock issued (in shares)		19
Common stock issued	$ 0
Repurchases of common stock (in shares)	(4,000)	(4)
Repurchases of common stock	$ (2,484)	$ (2,484)
Stock-based compensation expense	60,107	$ 60,107
Ending balance (in shares) at Jun. 30, 2025		47,892
Ending balance at Jun. 30, 2025	$ 3,209,970	$ 822,582	2,411,079	(23,691)
Beginning balance (in shares) at Dec. 31, 2025	48,709	48,709
Beginning balance at Dec. 31, 2025	$ 3,531,497	$ 936,998	2,609,651	(15,152)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	450,524		450,524
Other comprehensive income	15,661			15,661
Dividends and dividend equivalents declared	(198,322)		(198,322)
Common stock issued (in shares)		436
Common stock issued	$ 5,830	$ 5,830
Repurchases of common stock (in shares)	(3,000)	(3)
Repurchases of common stock	$ (4,048)	$ (4,048)
Stock-based compensation expense	$ 94,282	$ 94,282
Ending balance (in shares) at Jun. 30, 2026	49,142	49,142
Ending balance at Jun. 30, 2026	$ 3,895,424	$ 1,033,062	2,861,853	509
Beginning balance (in shares) at Mar. 31, 2026		49,129
Beginning balance at Mar. 31, 2026	3,677,410	$ 983,926	2,703,596	(10,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	257,298		257,298
Other comprehensive income	10,621			10,621
Dividends and dividend equivalents declared	(99,041)		(99,041)
Common stock issued (in shares)		16
Common stock issued	$ 0
Repurchases of common stock (in shares)	(3,000)	(3)
Repurchases of common stock	$ (4,048)	$ (4,048)
Stock-based compensation expense	$ 53,184	$ 53,184
Ending balance (in shares) at Jun. 30, 2026	49,142	49,142
Ending balance at Jun. 30, 2026	$ 3,895,424	$ 1,033,062	$ 2,861,853	$ 509